MAPT and Alzheimer disease: Clinical diagnosis of lvPPA (as above) + ≥1 of: • Histopathologic evidence of a specific neurodegenerative pathology (AD, FTLD-tau, FTLD-TDP, other) • Presence of a known pathogenic mutation